Fig. 1 · Structure
Documents & Downloads
RS5517
NHERF1 Antagonist
RS5517 is a selective antagonist of the PDZ1 domain of NHERF1, effectively inhibiting its ectopic nuclear localization. This compound demonstrates potential for studying the role of NHERF1 in colorectal cancer and may provide insights into its involvement in tumorigenesis and progression. Researchers can utilize RS5517 to explore novel therapeutic strategies targeting NHERF1-mediated pathways in cancer.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 2227017-46-9 |
| Applications | NHERF1 Antagonist |
| Formula | C23H19ClN2O2 |
| Molecular Weight | 390.86 |
| SMILES | O=C(C1=C(CC2=CC=CC=C2)C3=C(C=CC(Cl)=C3)N1)NC4=CC=C(CO)C=C4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.